Selective disruption of heparin and antithrombin‐mediated regulation of human factor IX

E-ISSN： 1538-7836|13|6|1053-1063

ISSN： 1538-7933

Source： JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.13, Iss.6, 2015-06, pp. : 1053-1063

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In vitro and in vivo evaluation of heparin mediated growth factor release from tissue‐engineered constructs for anterior cruciate ligament reconstruction

JOURNAL OF ORTHOPAEDIC RESEARCH, Vol. 33, Iss. 2, 2015-02 ,pp. : 229-236

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expression and functional characterization of two natural heparin‐binding site variants of antithrombin

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 16, Iss. 2, 2018-02 ,pp. : 330-341

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vitronectin Regulation of Vascular Endothelial Growth Factor-Mediated Angiogenesis

Journal of Vascular Research, Vol. 51, Iss. 2, 2014-03 ,pp. : 110-117

Karger

Access to resources Recommend Favorite

In vivo efficacy of human recombinant factor IX produced by the human hepatoma cell line HuH‐7

HAEMOPHILIA, Vol. 21, Iss. 4, 2015-07 ,pp. : e317-e321

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment effects of high‐dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 4, Iss. 1, 2006-01 ,pp. : 90-97

John Wiley & Sons Inc

Access to resources Recommend Favorite